Cargando…
Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease presenting with extreme fatigue, post-exertional malaise, and other symptoms. In the absence of a diagnostic biomarker, ME/CFS is diagnosed clinically, although laboratory tests are routinely used to exclude altern...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627354/ https://www.ncbi.nlm.nih.gov/pubmed/30974900 http://dx.doi.org/10.3390/diagnostics9020041 |
_version_ | 1783434718632476672 |
---|---|
author | Nacul, Luis de Barros, Barbara Kingdon, Caroline C. Cliff, Jacqueline M. Clark, Taane G. Mudie, Kathleen Dockrell, Hazel M. Lacerda, Eliana M. |
author_facet | Nacul, Luis de Barros, Barbara Kingdon, Caroline C. Cliff, Jacqueline M. Clark, Taane G. Mudie, Kathleen Dockrell, Hazel M. Lacerda, Eliana M. |
author_sort | Nacul, Luis |
collection | PubMed |
description | Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease presenting with extreme fatigue, post-exertional malaise, and other symptoms. In the absence of a diagnostic biomarker, ME/CFS is diagnosed clinically, although laboratory tests are routinely used to exclude alternative diagnoses. In this analytical cross-sectional study, we aimed to explore potential haematological and biochemical markers for ME/CFS, and disease severity. We reviewed laboratory test results from 272 people with ME/CFS and 136 healthy controls participating in the UK ME/CFS Biobank (UKMEB). After corrections for multiple comparisons, most results were within the normal range, but people with severe ME/CFS presented with lower median values (p < 0.001) of serum creatine kinase (CK; median = 54 U/L), compared to healthy controls (HCs; median = 101.5 U/L) and non-severe ME/CFS (median = 84 U/L). The differences in CK concentrations persisted after adjusting for sex, age, body mass index, muscle mass, disease duration, and activity levels (odds ratio (OR) for being a severe case = 0.05 (95% confidence interval (CI) = 0.02–0.15) compared to controls, and OR = 0.16 (95% CI = 0.07–0.40), compared to mild cases). This is the first report that serum CK concentrations are markedly reduced in severe ME/CFS, and these results suggest that serum CK merits further investigation as a biomarker for severe ME/CFS. |
format | Online Article Text |
id | pubmed-6627354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66273542019-07-23 Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study Nacul, Luis de Barros, Barbara Kingdon, Caroline C. Cliff, Jacqueline M. Clark, Taane G. Mudie, Kathleen Dockrell, Hazel M. Lacerda, Eliana M. Diagnostics (Basel) Article Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease presenting with extreme fatigue, post-exertional malaise, and other symptoms. In the absence of a diagnostic biomarker, ME/CFS is diagnosed clinically, although laboratory tests are routinely used to exclude alternative diagnoses. In this analytical cross-sectional study, we aimed to explore potential haematological and biochemical markers for ME/CFS, and disease severity. We reviewed laboratory test results from 272 people with ME/CFS and 136 healthy controls participating in the UK ME/CFS Biobank (UKMEB). After corrections for multiple comparisons, most results were within the normal range, but people with severe ME/CFS presented with lower median values (p < 0.001) of serum creatine kinase (CK; median = 54 U/L), compared to healthy controls (HCs; median = 101.5 U/L) and non-severe ME/CFS (median = 84 U/L). The differences in CK concentrations persisted after adjusting for sex, age, body mass index, muscle mass, disease duration, and activity levels (odds ratio (OR) for being a severe case = 0.05 (95% confidence interval (CI) = 0.02–0.15) compared to controls, and OR = 0.16 (95% CI = 0.07–0.40), compared to mild cases). This is the first report that serum CK concentrations are markedly reduced in severe ME/CFS, and these results suggest that serum CK merits further investigation as a biomarker for severe ME/CFS. MDPI 2019-04-10 /pmc/articles/PMC6627354/ /pubmed/30974900 http://dx.doi.org/10.3390/diagnostics9020041 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nacul, Luis de Barros, Barbara Kingdon, Caroline C. Cliff, Jacqueline M. Clark, Taane G. Mudie, Kathleen Dockrell, Hazel M. Lacerda, Eliana M. Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study |
title | Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study |
title_full | Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study |
title_fullStr | Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study |
title_full_unstemmed | Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study |
title_short | Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study |
title_sort | evidence of clinical pathology abnormalities in people with myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) from an analytic cross-sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627354/ https://www.ncbi.nlm.nih.gov/pubmed/30974900 http://dx.doi.org/10.3390/diagnostics9020041 |
work_keys_str_mv | AT naculluis evidenceofclinicalpathologyabnormalitiesinpeoplewithmyalgicencephalomyelitischronicfatiguesyndromemecfsfromananalyticcrosssectionalstudy AT debarrosbarbara evidenceofclinicalpathologyabnormalitiesinpeoplewithmyalgicencephalomyelitischronicfatiguesyndromemecfsfromananalyticcrosssectionalstudy AT kingdoncarolinec evidenceofclinicalpathologyabnormalitiesinpeoplewithmyalgicencephalomyelitischronicfatiguesyndromemecfsfromananalyticcrosssectionalstudy AT cliffjacquelinem evidenceofclinicalpathologyabnormalitiesinpeoplewithmyalgicencephalomyelitischronicfatiguesyndromemecfsfromananalyticcrosssectionalstudy AT clarktaaneg evidenceofclinicalpathologyabnormalitiesinpeoplewithmyalgicencephalomyelitischronicfatiguesyndromemecfsfromananalyticcrosssectionalstudy AT mudiekathleen evidenceofclinicalpathologyabnormalitiesinpeoplewithmyalgicencephalomyelitischronicfatiguesyndromemecfsfromananalyticcrosssectionalstudy AT dockrellhazelm evidenceofclinicalpathologyabnormalitiesinpeoplewithmyalgicencephalomyelitischronicfatiguesyndromemecfsfromananalyticcrosssectionalstudy AT lacerdaelianam evidenceofclinicalpathologyabnormalitiesinpeoplewithmyalgicencephalomyelitischronicfatiguesyndromemecfsfromananalyticcrosssectionalstudy |